— Know what they know.
Not Investment Advice

VERU NASDAQ

Veru Inc.
1W: -1.2% 1M: -8.7% 3M: -11.3% YTD: +10.6% 1Y: -35.5% 3Y: -67.8% 5Y: -97.2%
$2.51
-0.03 (-1.18%)
 
Weekly Expected Move ±5.3%
$2 $2 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 44 · $40.3M mcap · 14M float · 14.39% daily turnover · Short 48% of daily vol

Supply Chain Overview

13 relationships
8
As Filer
counterparties named
5
As Counterparty
mentioned by others
4
Rel. Types
2023-04-20
Earliest Filing
2025-09-26
Latest Filing
acquirer: 4 investor: 2 target: 1 partner: 1

Counterparties (Filed by VERU)

8 relationships

Companies named in VERU's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Veru Inc. VERU acquirer Company selling FC2 business assets and stock 2025-01-03 View
The Female Health Company Limited — target Wholly owned subsidiary of Veru Inc. selling FC2 business 2025-01-03 View
Clear Future, Inc. — acquirer Purchaser of FC2 business assets and stock 2025-01-03 View
Lincoln Park Capital Fund, LLC — investor Investor in a purchase agreement for up to $50 million of common stock following an amendment to the original $100 milli 2023-12-13 View
Blue Water Biotech Inc. — acquirer Purchaser in asset purchase agreement amended to settle promissory note with issuance of Series A Preferred Stock 2023-10-02 View
Jefferies LLC JEF partner Sales agent for the Open Market Sale Agreement 2023-05-12 View
Lincoln Park Capital Fund, LLC — investor Entered into a purchase agreement and registration rights agreement to purchase up to $100,000,000 of Veru Inc. common s 2023-05-03 View
Blue Water Vaccines Inc. — acquirer Purchased substantially all assets related to Veru Inc.'s ENTADFI business for $20.0 million plus potential milestones. 2023-04-20 View

Mentioned As Counterparty

5 mentions

Other companies that named VERU in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
ONCO Onconetix, Inc. supplier Counterparty in asset purchase agreement and settlement regarding Veru's ENTADFI business assets and outstanding notes. 2025-09-26 View
ONCO Onconetix, Inc. partner Holds existing debt obligations and entered into multiple forbearance and waiver agreements regarding asset purchase not 2025-08-12 View
ONCO Onconetix, Inc. partner Asset purchase agreement and forbearance agreement regarding notes payable 2024-12-03 View
ONCO Onconetix, Inc. partner Asset purchase agreement and forbearance agreement regarding notes payable 2024-04-26 View
ONCO Blue Water Vaccines Inc. acquirer Seller of ENTADFITM business assets in an asset purchase agreement. 2023-04-20 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-08 Other Events; Exhibits View
2026-08-10 Earnings Release; Exhibits View
2026-07-02 Material Agreement; Exhibits Agreement View
2026-06-04 Other Events View
2026-05-13 Earnings Release; Exhibits View
2026-03-13 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2026-02-11 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-12-17 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-30 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2025-09-26 Termination of Material Definitive Agreement; Financial Statements and Exhibits View
2025-08-27 Other Events View
2025-08-12 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-08-12 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2025-07-25 Submission of Matters to a Vote of Security Holders View
2025-05-08 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-03-14 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2025-02-28 Notice of Delisting or Transfer View
2025-02-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-01-03 Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Completion o Agreement Acquisition View
2024-09-20 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms